Osteoporosis International

, Volume 24, Issue 3, pp 1101–1105 | Cite as

Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency

  • T. DiamondEmail author
  • Y. K. Wong
  • T. Golombick
Short Communication



Treatment of vitamin D deficiency for 3 months with oral cholecalciferol 5,000 IU daily was more effective than 2,000 IU daily in achieving optimal serum 25-hydroxyvitamin D (25OHD) concentrations. Optimal 25OHD serum level calculated to be 63.8 nmol/L. All parameters of muscle strength improved following administration of cholecalciferol for 3 months.


The aim of this study was to determine the optimal dose of cholecalciferol required to achieve target serum 25OHD level 75 nmol/L and its relationship to both bone turnover and muscle strength.


Thirty deficient patients (serum 25OHD ≤50 nmol/L) were randomly assigned into two groups—i.e. 2,000 and 5,000 IU/day. Data were collected at baseline, at 2 and 3 months post-therapy: (a) clinical demographics, (b) dietary calcium recall, (c) physical tests of muscle function and (d) biochemistry. Statistical analysis used paired student t test and analysis of variance. Regression analysis was used to determine relationship between serum 25OHD and parathyroid hormone (PTH).


Twenty-six (87%) patients completed 3 months of therapy. The percent increase in serum 25OHD (compared to baseline) was 82.7% in 2,000-IU group and 219.5% in 5,000-IU group. All participants (100%) achieved a serum 25OHD concentration >50 nmol/L; only 5 subjects (45.4%) in 2,000-IU group compared to 14 subjects (93.3%) in 5,000-IU group achieved final 25OHD concentration ≥75 nmol/L (p < 0.01). In the regression analysis, the reflexion point at which the PTH level increased above the normal range was calculated to be 63.8 nmol/L 25OHD. All parameters of muscle strength showed trends in improvements following the administration of both the 2,000 and 5,000 IU doses. No patient reported untoward side effects and no patient developed hypercalcaemia.


Treatment for 3 months with oral cholecalciferol 5,000 IU daily may be more effective than 2,000 IU daily in achieving optimal serum 25OHD concentrations in vitamin D-deficient patients.


Bone turnover Muscle strength Vitamin D deficiency 


Conflicts of interest



  1. 1.
    DeLuca HF, Zierold C (2008) Mechanisms and functions of vitamin D. Nutr Rev 56(2):4–10Google Scholar
  2. 2.
    Diamond T, Mason RS (2009) Understanding the importance of vitamin D for bone and systemic health. Medicine Today 10(1):18–25Google Scholar
  3. 3.
    Van der Mei IAF, Ponsonby A, Engelsen O et al (2007) The high prevalence of vitamin D insufficiency across Australian populations is only explained by season and latitude. Environ Heal Perspect 56(2):4–10Google Scholar
  4. 4.
    Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(4):1080S–1086SPubMedGoogle Scholar
  5. 5.
    Bischoff-Ferrari HA, Giovannucci E, Willet WC et al (2006) Estimations of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutrition 84:18–28Google Scholar
  6. 6.
    Wark JD (2003) Calcium supplementation: the bare bones. Aust Prescr 26(6):126–127Google Scholar
  7. 7.
    Ewing‐Fess E (1987) A method for checking jamar dynamometer calibration, J Hand Ther 1(1):28–32Google Scholar
  8. 8.
    McCarthy EK, Horvat MA, Holtsberg PA, Wisenbaker JM (2004) Repeated chair stands as a measure of lower limb strength in sexagenarian women. Journals of Gerontology Series A- Biological Sciences and Medical Science 59(11):1207–1212CrossRefGoogle Scholar
  9. 9.
    Hackman KL, Gagnon C, Briscoe RK et al (2010) Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Medical Journal Australia 192(12):686–689Google Scholar
  10. 10.
    Kuchuk NO, Plujim SM, van Schoor et al (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94(4):1244–1250PubMedCrossRefGoogle Scholar
  11. 11.
    Prabhala A, Garg R, Dandona P (2000) Severe myopathy associated with Vitamin D deficiency in Western New York. Arch Intern Med 160:1244–1250CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2012

Authors and Affiliations

  1. 1.Department EndocrinologySt George HospitalKogarahAustralia

Personalised recommendations